Get started
KOLON TISSUEGENE, INC.KOLON TISSUEGENE, INC.KOLON TISSUEGENE, INC.

KOLON TISSUEGENE, INC.

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

950160 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Kolon TissueGene, Inc. is a biopharmaceutical company, which engages in the development of clinical-stage cell therapies for osteoarthritis. It offers TG-C, a platform technology that consists of a combination of allogeneic primary cells combined with genetically modified cells. The company was founded by Kwan H. Lee on June 9, 1999 and is headquartered in Rockville, MD.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
950160 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company